Dong-Jing Fu

Dong-Jing Fu

UNVERIFIED PROFILE

Are you Dong-Jing Fu?   Register this Author

Register author
Dong-Jing Fu

Dong-Jing Fu

Publications by authors named "Dong-Jing Fu"

Are you Dong-Jing Fu?   Register this Author

38Publications

761Reads

40Profile Views

Paliperidone Palmitate Once-Monthly Treatment in Recent Onset and Chronic Illness Patients With Schizoaffective Disorder.

J Nerv Ment Dis 2017 Apr;205(4):324-328

*Janssen Scientific Affairs, LLC; †Janssen Research and Development, LLC; and ‡CNS Janssen Pharmaceutical, LLC, Titusville, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/NMD.0000000000000646DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380018PMC
April 2017

Genome-wide association study of paliperidone efficacy.

Pharmacogenet Genomics 2017 01;27(1):7-18

aNeuroscience, Janssen Research & Development, LLC bJanssen Scientific Affairs, LLC, Titusville cJanssen Research & Development, LLC, Raritan dBlue Note Biosciences, LLC, Princeton, New Jersey eBiostatistics and Bioinformatics, The Scripps Translational Science Institute fDepartment of Molecular and Experimental Medicine, The Scripps Research Institute gScripps Health hHuman Biology, J. Craig Venter Institute, La Jolla iMD Revolution, San Diego, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000250DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152628PMC
January 2017

Benefit-risk assessment of paliperidone oral extended-release tablet versus monthly injectable for maintenance treatment of schizophrenia.

Int Clin Psychopharmacol 2016 11;31(6):315-22

aJanssen Research and Development, LLC bJanssen Scientific Affairs, LLC, Titusville, New Jersey, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/YIC.0000000000000141DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049945PMC
November 2016

Treatment Patterns and Antipsychotic Medication Adherence Among Commercially Insured Patients With Schizoaffective Disorder in the United States.

J Clin Psychopharmacol 2016 Oct;36(5):429-35

From the *Janssen Scientific Affairs, LLC, Titusville; and †Novosys Health, Green Brook, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCP.0000000000000549DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017269PMC
October 2016

Paliperidone for the treatment of schizoaffective disorder.

Expert Opin Pharmacother 2016 24;17(6):871-83. Epub 2016 Mar 24.

b Statistics and Decision Sciences, Janssen Research and Development, LLC , Titusville , NJ , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2016.1161029DOI Listing
August 2016

Paliperidone Palmitate Once-Monthly Injectable Treatment for Acute Exacerbations of Schizoaffective Disorder.

J Clin Psychopharmacol 2016 Aug;36(4):372-6

From the *Janssen Scientific Affairs, LLC; †Janssen Research & Development, LLC, Titusville, NJ; ‡Collaborative Neuroscience Network, Inc, Garden Grove, CA; §SUNY Downstate Medical Center, Brooklyn; and ∥New York University, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JCP.0000000000000535DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932150PMC
August 2016

Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy.

Int Clin Psychopharmacol 2016 07;31(4):202-9

aJanssen Scientific Affairs bJanssen Research & Development, LLC, Titusville, New Jersey cSaint Louis University School of Medicine, St Louis, Missouri, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/YIC.0000000000000125DOI Listing
July 2016

The Direct and Indirect Effects of Paliperidone Extended-release on Depressive Symptoms in Schizoaffective Disorder: A Path Analysis.

Innov Clin Neurosci 2015 Nov-Dec;12(11-12):10-7

Dr. Turkoz is with Janssen Research and Development LLC, Titusville, New Jersey, USA, and Drs. Fu, Bossie, and Alphs are with Janssen Scientific Affairs LLC, Titusville, New Jersey, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4756793PMC
May 2016

Rapid onset of treatment effects on psychosis, depression, and mania in patients with acute exacerbation of schizoaffective disorder following treatment with oral extended-release paliperidone.

J Affect Disord 2016 Mar 31;193:381-90. Epub 2015 Dec 31.

Janssen Scientific Affairs, LLC, 1125 Trenton-Harbourton Road-A32404, Titusville, NJ 08560, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jad.2015.12.060DOI Listing
March 2016

Comparing Injection Site Pain with Paliperidone Palmitate Versus First-Generation Depot Antipsychotics in Subjects with Schizophrenia.

Innov Clin Neurosci 2015 May-Jun;12(5-6):10-1

Gopal and Nuamah are with Janssen Research & Development, LLC, Titusville, New Jersey, United States; Palermo is with Johnson County Mental Health, Shawnee, Kansas, United States; and Sliwa, Fu, and Alphs are with Janssen Scientific Affairs, LLC, Titusville, New Jersey, United States.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479357PMC
July 2015

SULT4A1 haplotype: conflicting results on its role as a biomarker of antipsychotic response.

Pharmacogenomics 2014 ;15(12):1557-64

Neuroscience Therapeutic Area, Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.14.105DOI Listing
June 2015

Large-scale candidate gene study to identify genetic risk factors predictive of paliperidone treatment response in patients with schizophrenia.

Pharmacogenet Genomics 2015 Apr;25(4):173-85

aJanssen Research & Development, LLC, Raritan bJanssen Scientific Affairs, LLC, Titusville, New Jersey cJanssen Research & Development, LLC, Titusville, New Jersey, USA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/FPC.0000000000000122DOI Listing
April 2015

Onset and persistence of efficacy by symptom domain with long-acting injectable paliperidone palmitate in patients with schizophrenia.

Expert Opin Pharmacother 2014 May;15(7):1029-42

Therapeutic Area Leader Psychiatry, Janssen Scientific Affairs, LLC , 1125 Trenton-Harbourton Road-A32404, Titusville, NJ 08560 , USA +1 609 730 3693 ; +1 609 730 3125 ;

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1517/14656566.2014.90
Publisher Site
http://dx.doi.org/10.1517/14656566.2014.909409DOI Listing
May 2014

Paliperidone palmitate versus oral risperidone and risperidone long-acting injection in patients with recently diagnosed schizophrenia: a tolerability and efficacy comparison.

Int Clin Psychopharmacol 2014 Jan;29(1):45-55

aMedical Affairs bMedical Information, Janssen Scientific Affairs, LLC cBiostatistics, B&P, Janssen Research & Development, LLC, Titusville, New Jersey, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00004850-201401000-000
Publisher Site
http://dx.doi.org/10.1097/YIC.0000000000000006DOI Listing
January 2014

Comments on the scoring guideline of the personal and social performance scale (PSP).

Schizophr Res 2014 Jan 26;152(1):304. Epub 2013 Nov 26.

Janssen Scientific Affairs, LLC, Titusville, NJ, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.schres.2013.10.039DOI Listing
January 2014

Relationship between the clinical global impression of severity for schizoaffective disorder scale and established mood scales for mania and depression.

J Affect Disord 2013 Aug 18;150(1):17-22. Epub 2013 Mar 18.

Janssen Research & Development, LLC, 1125 Trenton-Harbourton Road, Titusville, NJ 08650, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jad.2013.01.047DOI Listing
August 2013

Development and psychometric evaluation of a clinical global impression for schizoaffective disorder scale.

Innov Clin Neurosci 2012 Jan;9(1):15-24

Colorado Depression Center at the University of Colorado School of Medicine, Aurora, Colorado, and VISN 19 Suicide MIRECC, Denver, Colorado, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280074PMC
January 2012

Role of paliperidone extended-release in treatment of schizoaffective disorder.

Neuropsychiatr Dis Treat 2010 Oct 5;6:667-79. Epub 2010 Oct 5.

External Innovation Neuroscience Therapeutic Area, Johnson & Johnson Pharmaceutical Research and Development, 1125 Trenton-Harbourton Road, Titusville, NJ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/NDT.S12612DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951750PMC
October 2010

Genetic polymorphisms in human proton-dependent dipeptide transporter PEPT1: implications for the functional role of Pro586.

J Pharmacol Exp Ther 2004 Aug 9;310(2):437-45. Epub 2004 Apr 9.

Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285, USA.

View Article

Download full-text PDF

Source
http://jpet.aspetjournals.org/cgi/doi/10.1124/jpet.104.06591
Publisher Site
http://dx.doi.org/10.1124/jpet.104.065912DOI Listing
August 2004

Genotyping with TaqMAMA.

Genomics 2004 Feb;83(2):311-20

Department of Lead Optimization Toxicology, A Division of Eli Lilly and Company, 2001 West Main Street, Greenfield, IN 46140, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygeno.2003.08.005DOI Listing
February 2004